University Cancer & Blood Center
University Cancer & Blood Center is a private, multi-specialty oncology and hematology practice operating 13 locations across Northeast Georgia, delivering integrated medical, radiation, and surgical oncology plus specialized programs in theranostics, breast health, and clinical trials.
- Company typePrivate
- Founded1981
- HeadquartersAthens, United States
- Headcount251–500
- GTM typeB2C
- OfferingServices
What University Cancer & Blood Center does
University Cancer & Blood Center (UCBC) is a private, multi-specialty oncology and hematology practice headquartered in Athens, Georgia, delivering comprehensive cancer care across 13 locations in Northeast Georgia. The practice traces its origins to 1981 and operates as a vertically integrated provider combining medical oncology, radiation oncology, surgical oncology, hematology, and a Comprehensive Breast Health Program under a single coordinated care model. Its service portfolio spans core treatment modalities (chemotherapy, external beam radiation, brachytherapy, systemic radiopharmaceuticals, tumor surgery), specialized clinics (Theranostics — the first in Georgia outside a hospital setting — Melanoma Clinic, High-Risk GI Clinic, Athens Brain Center, Acute Care Clinic), and supporting infrastructure including an in-house pharmacy, laboratory, CT imaging, flow cytometry, molecular testing, genetic counseling, and a Live Well integrative care program.
UCBC generates revenue primarily through professional services billed to insurance and patients across its multi-site clinical footprint, supplemented by participation in a clinical trials program covering 20+ cancer types through its NCI-affiliated research program. Distribution is direct and regional: patients access care via scheduled appointments, physician referrals, and hospital partnerships with Piedmont Athens Regional and St. Mary's, where UCBC's inpatient advanced practice providers serve as on-site care coordinators. Marketing emphasizes community presence and physician credentials rather than price competition, supported by a NavigatingCare patient portal and an active SNMMI-recognized Clinical Radiopharmaceutical Therapy Center of Excellence designation. The practice is governed as a physician-led private entity with no identified parent company or institutional investor ownership.
Customer acquisition is fundamentally regional, anchored in Northeast Georgia with selected extension into Greater Atlanta metro counties (e.g., Gwinnett and Newton). Recent operating cadence — including the Snellville opening (January 2024), Oconee Imaging Center (May 2025), construction of a new Athens Comprehensive Cancer Center, the addition of a board-certified surgical oncologist in 2023, and the SNMMI Center of Excellence designation in April 2026 — indicates a multi-year build-out of clinical capacity and credentials.
University Cancer & Blood Center firmographics
Firmographics- Name
- University Cancer & Blood Center
- Legal name
- University Cancer & Blood Center
- Website
- https://universitycancer.com
- Company type
- Private
- Founded year
- 1981
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Short description
- University Cancer & Blood Center is a private, multi-specialty oncology and hematology practice operating 13 locations across Northeast Georgia, delivering integrated medical, radiation, and surgical oncology plus specialized programs in theranostics, breast health, and clinical trials.
- Ownership category
- akta.pro rank
University Cancer & Blood Center industry classification
Industry- Product category
- Oncology and Hematology Healthcare Services
- NAICS
- Diagnostic Imaging Centers (621512), Medical and Diagnostic Laboratories (6215)
- SIC
- Services-Specialty Outpatient Facilities, Nec (8093), Services-Offices & Clinics Of Doctors Of Medicine (8011)
- akta.pro primary industry
- Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI)
- akta.pro secondary industries
- Nuclear Medicine Clinical Services & Therapy Centers (HLAIAGAI), Hospital-Integrated Cancer Centers (Acute Oncology Programs) (HLAFAAAM)
Keywords
Where University Cancer & Blood Center is headquartered
LocationHeadquarters
- HQ city
- Athens
- HQ country
- United States
- HQ region
- North America
Offices13 records
Markets served
University Cancer & Blood Center business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain
Revenue model
- Patient Care Services: Revenue generated from comprehensive oncology and hematology healthcare services including medical oncology, radiation oncology, surgical oncology, diagnostic imaging, laboratory services, pharmacy, and supportive care. Billed through insurance reimbursement and patient payments.
- Clinical Trial Participation: Revenue and resources obtained through participation in clinical trials, providing access to investigational therapies while contributing to cancer research advancement.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels7 records
University Cancer & Blood Center product offering
Product offeringCore offering
University Cancer & Blood Center (UCBC) is a multi-specialty oncology and hematology practice delivering comprehensive cancer care including medical oncology, surgical oncology, radiation oncology, hematology, and specialized programs such as breast health, theranostics, melanoma, and high-risk GI clinics. The practice operates across 13 locations in Northeast Georgia with an Athens-based Comprehensive Cancer Center that co-locates infusion, imaging, laboratory, pharmacy, and supportive services.
Product overview
University Cancer & Blood Center (UCBC) is a multi-specialty oncology and hematology practice offering a comprehensive, vertically integrated cancer care ecosystem. The core portfolio consists of three primary treatment pillars—Medical Oncology (chemotherapy and drug-based therapies), Radiation Oncology (external beam, brachytherapy, and systemic radiopharmaceuticals), and Surgical Oncology—augmented by specialized programs including the Comprehensive Breast Health Program (3D mammography, breast surgery, lymphedema management), Theranostics (first in Georgia outside a hospital), Athens Brain Center, Melanoma Clinic, High-Risk GI Clinic, and Hematology services. UCBC delivers care through 13 area locations across Northeast Georgia, anchored by its Athens Comprehensive Cancer Center where private infusion, in-house laboratory, CT imaging, molecular testing, genetic counseling, UCBC Pharmacy, and the Acute Care Clinic are co-located. The Live Well integrative care program provides psychosocial, nutritional, and financial support, while an active Clinical Trials program spans 20+ cancer types. Patient-facing digital tools include a NavigatingCare patient portal and a bill payment portal, supported by an Inpatient APP program at affiliated hospitals. The organization traces its roots to Athens, Georgia since 1981.
Differentiator
Problem solved
Functional benefit
Products and services
- Medical Oncology Comprehensive cancer treatment using chemotherapy, hormone therapy, and other drug-based therapies. UCBC oncologists guide patients through diagnosis, treatment planning, and post-treatment care.
- Radiation Oncology Treatment using precisely targeted high-energy radiation to kill cancer cells, including external beam radiation therapy, brachytherapy, and systemic radiopharmaceuticals (LUTATHERA, Xofigo, Pluvicto).
- Surgical Oncology Surgical removal of tumors and affected tissues, including liver, melanoma, pancreatic, gastrointestinal, retroperitoneal sarcoma, neuroendocrine tumors, and gallbladder cancers.
- Hematology Treatment of benign and malignant blood disorders including anemias, blood transfusions, bone marrow transplantations, hemophilia, leukemias, lymphomas, multiple myeloma, and thrombotic conditions.
- Comprehensive Breast Health Program Multidisciplinary breast health services including 3D mammography screening and diagnostics, high-risk breast program with genetic testing and counseling, breast surgery, medical and radiation oncology, and lymphedema management.
- Theranostics First cancer center in Georgia to offer Theranostics outside a hospital setting, combining diagnostic PET scan imaging with targeted radiopharmaceutical therapy (LUTATHERA, Xofigo, Pluvicto) for neuroendocrine tumors and prostate cancer.
- High-Risk GI Clinic Gastrointestinal cancer risk assessment, screening, and surveillance for patients with pre-cancerous conditions or genetic risk factors, including colorectal, gastric, or pancreatic cancers.
- Melanoma Clinic Multidisciplinary melanoma treatment program involving dermatologists, medical oncologists, surgical oncologists, radiation oncologists, and ENT specialists, including SPECT imaging for lymph node identification.
- Athens Brain Center Brain cancer treatment division offering radiation therapy and other advanced treatments for brain and spinal cord tumors, led by Dr. Gordon O. Schoenfeld.
- Acute Care Clinic Same-day oncology urgent care clinic for UCBC patients experiencing adverse cancer treatment side effects, staffed by oncology-trained providers.
- UCBC Pharmacy Full-service retail pharmacy within the Comprehensive Cancer Center staffed with certified pharmacists, accepting most major insurance and stocking difficult-to-find medications.
- In-House Laboratory and Imaging Services In-house diagnostic capabilities including CT imaging, flow cytometry, molecular testing, and genetic counseling, enabling rapid diagnosis and treatment planning.
- Live Well Integrative Care Program Holistic patient support program including integrative therapies, psychosocial counseling, nutrition counseling, palliative care, and financial support services.
- Clinical Trials Program Active clinical trial program across 20+ cancer types, described as the second most prolific clinical trial facility in Georgia.
- Inpatient Advanced Practice Provider Program On-site APP staff at Piedmont Athens and St. Mary's Hospitals serving as personal patient advocates to coordinate care for hospitalized UCBC patients.
Quantifiable outcome
- 92% of breast cancer survivors had progression of secondary lymphedema stopped through three years using L-Dex Technology
Companies that use University Cancer & Blood Center
Customer profileNamed customers5 records
Segments4 records
Ideal customer profiles4 records
University Cancer & Blood Center technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
University Cancer & Blood Center partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered core, secondary and minor.
- University Health AlliancecoreUCBC partnered with University Health Alliance to open the High-Risk GI Clinic, a state-of-the-art program featuring acclaimed physicians and experts in oncology and gastroenterology for patients at high risk of gastrointestinal cancer.
- Cancer Foundation of Northeast GeorgiacoreUCBC established the Cancer Foundation of Northeast Georgia in 2005 to help offset the extreme financial burden that a cancer diagnosis and subsequent treatment can place on families. The foundation benefits not only UCBC patients but all those within the Northeast Georgia region, providing financial support services.
- National Cancer Institute (NCI)coreUCBC maintains affiliation with the National Cancer Institute (NCI), operating as a clinical trial site and part of a global community of cancer researchers working toward common goals in cancer treatment advancement.
- Piedmont Athens RegionalcoreUCBC's Inpatient APP staff are on-site as personal patient advocates at Piedmont Athens Hospital to coordinate care and optimize outcomes for UCBC patients receiving hospital treatment.
- St. Mary's HospitalcoreUCBC's Inpatient APP staff are on-site as personal patient advocates at St. Mary's Hospital to coordinate care and optimize outcomes for UCBC patients receiving hospital treatment.
- ENT of AthenssecondaryUCBC collaborates with ENT of Athens for multidisciplinary melanoma treatment, particularly for melanomas on the head and neck requiring facial plastic surgery expertise.
- Dermatology SpecialistssecondaryUCBC collaborates with dermatology specialists as part of the multidisciplinary melanoma clinic for skin assessment, biopsy, and ongoing dermatology care.
- Choice Awards AthensminorUCBC receives community recognition through Choice Awards Athens.
Scale indicators6 records
Recent moves9 records
Expansion highlights5 records
University Cancer & Blood Center competitors and assessment
Company assessmentDirect peers
- Tennessee Oncology: Large independent community oncology practice serving Tennessee with medical, radiation, and gynecologic oncology across multiple locations. Closely comparable multi-site, physician-led oncology model serving a regional catchment area.
- Florida Cancer Specialists & Research Institute: Largest independent oncology and hematology practice in the United States, operating nearly 100 locations across Florida. Closely comparable vertically integrated model with in-house lab, imaging, pharmacy, and clinical trials program.
- Maryland Oncology Hematology: Independent community oncology practice operating across Maryland with medical oncology, radiation oncology, and clinical trials. Comparable multi-location, physician-led regional model with similar payer mix dynamics.
- Oncology Hematology Care (OHC): Independently owned community oncology and hematology practice serving the Greater Cincinnati tri-state area. Directly comparable independent multi-specialty practice with infusion, clinical trials, and supportive care services.
Broad incumbents
- American Oncology Network: PE-backed platform supporting independent community oncology practices with practice management, technology, and payer contracting. Relevant as both a competitor and a potential roll-up partner for UCBC.
- OneOncology: PE-backed partnership platform for independent community oncology practices, providing capital, technology, and operational support. Comparable as a consolidation alternative facing UCBC.
- Winship Cancer Institute of Emory University: National Cancer Institute-designated Comprehensive Cancer Center and academic oncology hub in metropolitan Atlanta. Direct competitor for complex oncology cases in UCBC's Georgia catchment, including for Theranostics and clinical trials.
- The US Oncology Network: McKesson-affiliated network of independent community oncology practices offering practice management, technology, and drug distribution. Comparable as a competing affiliation model for community oncologists.
Regional players
- Piedmont Cancer Institute: Hospital-affiliated oncology practice within the Piedmont Healthcare system in Georgia. Direct regional competitor sharing the same hospital partnership ecosystem as UCBC.
- Northwest Georgia Oncology Centers: Independent community oncology practice serving Northwest Georgia and metro Atlanta suburbs. Comparable independent, multi-site model in a different but adjacent Georgia geography.
Market position
Strengths5 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
University Cancer & Blood Center social profiles
Digital presenceUniversity Cancer & Blood Center compliance and trust
Trust signalCompliance5 records
University Cancer & Blood Center financial estimates
Financial estimateRevenue estimate
Valuation estimate
University Cancer & Blood Center leadership team
Management profileNumber of profiles
Profiles6 records
University Cancer & Blood Center subsidiaries and ownership
Company hierarchySubsidiaries2 records
University Cancer & Blood Center funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
University Cancer & Blood Center M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about University Cancer & Blood Center
What does University Cancer & Blood Center do?
University Cancer & Blood Center (UCBC) is a multi-specialty oncology and hematology practice delivering comprehensive cancer care including medical oncology, surgical oncology, radiation oncology, hematology, and specialized programs such as breast health, theranostics, melanoma, and high-risk GI clinics. The practice operates across 13 locations in Northeast Georgia with an Athens-based Comprehensive Cancer Center that co-locates infusion, imaging, laboratory, pharmacy, and supportive services.
Is University Cancer & Blood Center a public or private company?
University Cancer & Blood Center is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was University Cancer & Blood Center founded?
University Cancer & Blood Center was founded in 1981. It employs 251 to 500 people.
Where is University Cancer & Blood Center based?
University Cancer & Blood Center is headquartered in Athens, United States, in the North America region.
How does University Cancer & Blood Center make money?
Two revenue lines are on record. Patient Care Services are the primary driver. The others are clinical Trial Participation.
Who are University Cancer & Blood Center's main competitors?
Direct peers on record are Tennessee Oncology, Florida Cancer Specialists & Research Institute, Maryland Oncology Hematology and Oncology Hematology Care (OHC). Broad incumbents are American Oncology Network, OneOncology, Winship Cancer Institute of Emory University and The US Oncology Network. Regional players are Piedmont Cancer Institute and Northwest Georgia Oncology Centers.
Does University Cancer & Blood Center have an API?
No public API is recorded for University Cancer & Blood Center.
What industry is University Cancer & Blood Center in?
University Cancer & Blood Center's product category is Oncology and Hematology Healthcare Services. Its primary akta.pro industry code is HLAFABAI, Ambulatory Oncology Centers (Outpatient Chemo/Radiation), with a secondary code of HLAIAGAI, Nuclear Medicine Clinical Services & Therapy Centers. Its NAICS code is 621512 and its SIC code is 8093.